Here are five points:
1. Mr. Lucera will take over as CFO on Aug. 29.
2. He will work out of the company’s Shrewsbury, Mass., office.
3. Mr. Lucera will oversee the Valeritas’ capital-efficient commercial strategy.
4. He has more than 20 years of experience in biotechnology, specialty pharmaceutical and medical technology companies.
5. Mr. Lucera previously served as CFO of Canada-based Viventia Bio.
More articles on quality & infection control:
Antibiotic-resistant infections cost $20B annually & 5 more statistics
AmSurg centers participate in ASC Quality Measures
Study: Viruses striking in the morning are 10x more successful in infecting
